Faculty of Anesthesiology, Changhai Hospital, Naval Medical University/Second Military Medical University, PLA, Shanghai, People's Republic of China.
Department of Anesthesiology and Perioperative Medicine, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
Clin Interv Aging. 2024 Nov 8;19:1881-1889. doi: 10.2147/CIA.S473421. eCollection 2024.
To explore the effect of scalp nerve block (SNB) combined with intercostal nerve block (ICNB) on quality of recovery (QoR) after deep brain stimulation (DBS) in patients with Parkinson's disease (PD).
We conducted a prospective randomized controlled trial in which 88 patients with PD were randomly assigned to undergo SNB combined with ICNB (SNB group) or not (control group) before surgery. The primary outcome was the 15-item QoR (QoR-15) score 24 h after surgery. The secondary outcomes included QoR-15 scores at 72 h and 1 month after surgery, pain-related events, recovery events in post-anesthesia care unit (PACU), duration of anesthesia and surgery, and nerve block-related adverse events.
The QoR-15 score at 24 h after surgery was significantly higher in SNB group than Control group: 122.0 ± 7.6 vs 113.5 ± 11.3 ( = 0.006). SNB combined with ICNB improved QoR-15 scores at 72 h ( = 0.004) but not at 1 month after surgery ( = 0.230). The SNB group was positively related to QoR-15 scores 24 h after surgery (β = 8.92; 95% CI = 4.52~13.32) after adjusting for confounding variables. The numeric rating scale pain scores at PACU discharge and at 24 h, intraoperative opioid consumption, rescue analgesic use, and the incidence of postoperative nausea and vomiting (PONV) in SNB group were significantly lower than Control group ( < 0.05).
Preoperative SNB combined with ICNB improved QoR and analgesia after surgery, and reduced intraoperative opioid consumption and the incidence of PONV in patients with PD who underwent DBS.
探讨头皮神经阻滞(SNB)联合肋间神经阻滞(ICNB)对帕金森病(PD)患者脑深部刺激(DBS)术后恢复质量(QoR)的影响。
我们进行了一项前瞻性随机对照试验,将 88 例 PD 患者随机分为手术前接受 SNB 联合 ICNB(SNB 组)或不接受(对照组)。主要结局是术后 24 小时的 15 项 QoR(QoR-15)评分。次要结局包括术后 72 小时和 1 个月的 QoR-15 评分、疼痛相关事件、麻醉后监护病房(PACU)恢复事件、麻醉和手术持续时间以及神经阻滞相关不良事件。
SNB 组术后 24 小时 QoR-15 评分明显高于对照组:122.0 ± 7.6 比 113.5 ± 11.3( = 0.006)。SNB 联合 ICNB 可改善术后 72 小时 QoR-15 评分( = 0.004),但对术后 1 个月 QoR-15 评分无影响( = 0.230)。SNB 组与术后 24 小时 QoR-15 评分呈正相关(β=8.92;95%CI=4.52~13.32),在调整混杂变量后。SNB 组在 PACU 出院时和 24 小时的数字评分量表疼痛评分、术中阿片类药物用量、解救性镇痛药物使用以及术后恶心呕吐(PONV)发生率均显著低于对照组( < 0.05)。
术前 SNB 联合 ICNB 可改善 PD 患者 DBS 术后 QoR 和镇痛效果,减少术中阿片类药物用量和 PONV 发生率。